Requirement

PlantX Announces Monthly Gross Revenue of $1.2 Million in July 2022, Up 35% Year-over-Year

Retrieved on: 
Tuesday, August 16, 2022 - 1:30pm

PlantX generated monthly gross revenue of $1.2 million in July 2022, an increase of 35% compared to $910,000 in July 2021.

Key Points: 
  • PlantX generated monthly gross revenue of $1.2 million in July 2022, an increase of 35% compared to $910,000 in July 2021.
  • Gross profit for July 2022 was $468,000, or 39% gross margin, compared to gross profit of $318,000, or 35% gross margin in July 2021.
  • "As we see continued strong topline growth that, we are sharply focused on accelerating our path to profitability," said PlantX CEO, Lorne Rapkin.
  • "We have refined our operations especially when it comes to staffing, optimizing our marketing activities, and securing more favorable terms with suppliers.

3 Day Computer System Validation (CSV) Training Program (September 21-23, 2022) - ResearchAndMarkets.com

Retrieved on: 
Tuesday, August 9, 2022 - 11:12am

The "Computer System Validation (CSV) Training" training has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Computer System Validation (CSV) Training" training has been added to ResearchAndMarkets.com's offering.
  • This computer system validation course is designed to completely immerse you in the principles, methods, and best practices of Computer System Validation (CSV).
  • You will learn about the regulations that impact your systems and gain hands-on practice writing validation documents.
  • Many exercises on Validation Plan, the Requirements Traceability Matrix, and the Validation Summary Report.

Lumen Announces Early Tender Results

Retrieved on: 
Saturday, August 6, 2022 - 2:11am

(4) Includes the Maximum Tender Early Tender Premium (as defined in the Offer to Purchase and Solicitation Statement) for Notes validly tendered prior to the Early Tender Date (and not validly withdrawn) and accepted for purchase by the applicable offeror.

Key Points: 
  • (4) Includes the Maximum Tender Early Tender Premium (as defined in the Offer to Purchase and Solicitation Statement) for Notes validly tendered prior to the Early Tender Date (and not validly withdrawn) and accepted for purchase by the applicable offeror.
  • (5) As further described in the Offer to Purchase and Solicitation Statement, the Lumen Notes are also subject to the Series Tender Cap of $350,000,000.
  • Because the aggregate principal amount of Maximum Tender Notes validly tendered (and not validly withdrawn) at or prior to the Early Tender Date did not exceed the Aggregate Maximum Tender Amount or the Series Tender Cap, the applicable offeror intends to purchase all of the Maximum Tender Notes validly tendered (and not validly withdrawn) at or prior to the Early Tender Date on the terms described below.
  • Lumen and Lumen Technologies are registered trademarks of Lumen Technologies LLC in the United States.

PlantX Brings Little West Cold-Pressed Juices to Canada

Retrieved on: 
Wednesday, August 3, 2022 - 1:30pm

Since being acquired by PlantX, Little West has added new products and consumer-friendly bundles.

Key Points: 
  • Since being acquired by PlantX, Little West has added new products and consumer-friendly bundles.
  • "We have seen amazing success with our littlewest.com website, and since the founders of Little West are Canadian and so is PlantX, it was only natural for us to bring these amazing juices to Canada," said PlantX CEO, Lorne Rapkin.
  • The Little West Canadian e-commerce website features merchandise and different flavors of juice, available in kits and cleanses.
  • In addition to the Canadian e-commerce website, Little West Juices are available in retail locations in the United States, including Whole Foods and Pavilions.

Mobilum Technologies Completes Year-End Audit

Retrieved on: 
Monday, July 25, 2022 - 12:37pm

VANCOUVER, BC, July 25, 2022 /PRNewswire/ - Mobilum Technologies Inc. (the "Company") (CSE: MBLM) (OTC: MBLMF) (FRA: C0B), announces that audit work on its financial statements for the year-ended February 28, 2022 has now been completed, and the statements, along with the accompanying managements' discussion and analysis and officer certifications have been filed.

Key Points: 
  • VANCOUVER, BC, July 25, 2022 /PRNewswire/ - Mobilum Technologies Inc. (the "Company") (CSE: MBLM) (OTC: MBLMF) (FRA: C0B), announces that audit work on its financial statements for the year-ended February 28, 2022 has now been completed, and the statements, along with the accompanying managements' discussion and analysis and officer certifications have been filed.
  • Readers are encouraged to review these materials under the profile for the Company on the SEDAR website ( www.sedar.com ).
  • The Company anticipates that the Required Filings will be completed and filed on or before August 12, 2022.
  • Mobilum has offices in Canada, Estonia, Lithuania, Poland, and the United States.

Aware’s Expertise in Advanced Authentication Solutions to be Showcased at Identity Week Europe 2022

Retrieved on: 
Tuesday, June 28, 2022 - 2:00pm

With the market demanding advanced authentication and digital identity solutions to combat fraud and secure assets at ever increasing rates, Aware will showcase how its industry-leading biometric expertise and passwordless authentication solutions can help customers directly address these threats.

Key Points: 
  • With the market demanding advanced authentication and digital identity solutions to combat fraud and secure assets at ever increasing rates, Aware will showcase how its industry-leading biometric expertise and passwordless authentication solutions can help customers directly address these threats.
  • Identity Week Europe has always been an important event for Aware and the identity community as a whole, said chief commercial officer, Rob Mungovan.
  • One product Aware will be showcasing at Identity Week Europe is Knomi , its mobile biometric authentication framework.
  • If you are unable to attend Identity Week Europe 2022, learn more on Awares website here .

Jama Software® and Sparx Systems Enhance Best-of-breed Tools Integration to Strengthen Live Traceability™ Across Systems Development

Retrieved on: 
Wednesday, June 22, 2022 - 5:00pm

Jama Software's industry-leading platform helps organizations manage requirements with Live Traceability through the systems development process for proven cycle time reduction and quality improvement.

Key Points: 
  • Jama Software's industry-leading platform helps organizations manage requirements with Live Traceability through the systems development process for proven cycle time reduction and quality improvement.
  • Teams using a model-based systems engineering (MBSE) approach are provided an integration into another best-of-breed tool while maintaining Live Traceability within Jama Connect.
  • Jama Connect uniquely creates Live Traceability through siloed development, test, and risk activities to provide end-to-end compliance, risk mitigation, and process improvement.
  • Sparx Systems is a global software company specializing in high performance, visual modeling platforms for planning, designing, and constructing software-intensive systems.

Prospera Provides Amended Second Status Update

Retrieved on: 
Thursday, June 9, 2022 - 12:00pm

Under the securities laws of the provinces in which Prospera is a reporting issuer, the Interim Filings were to be filed by May 30, 2022.

Key Points: 
  • Under the securities laws of the provinces in which Prospera is a reporting issuer, the Interim Filings were to be filed by May 30, 2022.
  • Prospera is a Canadian natural resource company engaged in the acquisition, exploration, development and production of oil and gas properties with operations in Alberta and western Saskatchewan.
  • Although Prospera believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because Prospera can give no assurance that they will prove to be correct.
  • As a result, Prospera cannot guarantee that any forward-looking statement will materialize, and the reader is cautioned not to place undue reliance on any forward-looking information.

Cansortium Provides Bi-Weekly MCTO Status Update and Update Regarding Annual and Interim Financial Statements

Retrieved on: 
Wednesday, June 8, 2022 - 11:18pm

The MCTO does not affect the ability of other shareholders, including the public, to trade in securities of the Company.

Key Points: 
  • The MCTO does not affect the ability of other shareholders, including the public, to trade in securities of the Company.
  • Cansortium is a vertically-integrated cannabis company with licenses and operations in Florida, Pennsylvania, Michigan (through its in-market partner) and Texas.
  • In addition, any statements that refer to expectations, projections, or other characterizations of future events or circumstances contain forward-looking information.
  • Statements containing forward-looking information are not historical facts but instead represent management's expectations, estimates, and projections regarding future events.

INNOVA MEDICAL GROUP EARNS GMED CE MARK TO DISTRIBUTE ITS RAPID ANTIGEN SELF TEST THROUGHOUT EUROPE

Retrieved on: 
Wednesday, June 8, 2022 - 2:25pm

PASADENA, Calif., June 8, 2022 /PRNewswire/ -- Innova Medical Group, Inc., a global health screening and diagnostic innovator and world's largest manufacturer and distributor of lateral flow test kits, today announced it successfully earned its CE mark certification (certificate N° 39032) of the Innova SARS-CoV-2 Antigen Rapid Qualitative Self-Test through GMED LNE Group, a leading certification organization and a distinguished Notified Body of the European Commission covering a vast range of products covered under both Invitro Diagnostic and Medical Device Regulations.

Key Points: 
  • Innova's rapid antigen self tests are the cornerstone of the company's role as a key partner to nations and businesses.
  • A CE mark is an important distinction that allows the company to now sell its products across Europe.
  • This is a significant milestone in the company's global mission to advance and expand access to its antigen rapid self tests to more people worldwide.
  • The company is furthering its mission by applying for authorization and certifications in countries where rapid antigen self tests are needed most.